⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockNetherlandsNasdaqGS

ARGX

argenx SE

Healthcare · Biotechnology

1,002.31USD

-4.7600 (-0.47%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$7.52▲$6.7792
Next quarter$8.2▲$7.6383
Current year$29.03▲$25.8141
Next year$39.31▲$37.365

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$6.19$7.32+1.13 (+18.2%)
2026-03-31$4.92$5.52+0.60 (+12.1%)
2025-12-31$6.11$8.02+1.91 (+31.2%)
2025-09-30$4.16$5.18+1.02 (+24.5%)

Wall Street coverage

297 ratings from 34 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
WedbushReiteratedOutperform$1,150Sep 8, 2026
WedbushReiteratedOutperform$1,150Sep 3, 2026
Morgan StanleyMaintainedOverweight$1,230 $1,250Aug 31, 2026
UBSUpgraded from NeutralBuy$960 $1,400Aug 26, 2026
Wells FargoMaintainedOverweight$1,350 $1,415Aug 26, 2026
Truist SecuritiesMaintainedBuy$1,030 $1,095Aug 18, 2026
Morgan StanleyMaintainedOverweight$1,200 $1,230Aug 18, 2026
RBC CapitalMaintainedOutperform$1,025 $1,100Aug 18, 2026
CitizensMaintainedMarket Outperform$932 $1,200Aug 18, 2026
WedbushMaintainedOutperform$1,050 $1,150Aug 18, 2026
HC Wainwright & Co.MaintainedBuy$940 $1,202Aug 18, 2026
Piper SandlerMaintainedOverweight$1,075 $1,215Aug 17, 2026
WedbushMaintainedOutperform$1,000 $1,050Jul 28, 2026
BairdMaintainedNeutral$867 $932Jul 27, 2026
OppenheimerMaintainedOutperform$1,014 $1,037Jul 24, 2026
RBC CapitalMaintainedOutperform$945 $1,025Jul 24, 2026
GuggenheimMaintainedBuy$1,135 $1,185Jul 24, 2026
CitizensMaintainedMarket Outperform$944 $932Jul 24, 2026
CitigroupMaintainedBuy$1,152 $1,182Jul 21, 2026
RBC CapitalMaintainedOutperform$890 $945Jul 7, 2026
B of A SecuritiesMaintainedBuy$1,016 $1,088Jul 2, 2026
HC Wainwright & Co.ReiteratedBuy$940Jun 25, 2026
Morgan StanleyMaintainedOverweight$1,170 $1,180Jun 24, 2026
WedbushReiteratedOutperform$1,000Jun 11, 2026
WedbushReiteratedOutperform$1,000Jun 4, 2026

Analyst Notes

Sign in to write

No analyst notes on ARGX yet.

Analyst Ratings

23 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current16000Buy1.86
1 mo ago16000Buy1.86
2 mo ago614300Buy1.87
3 mo ago715300Buy1.84
Price target$1,179.74$900.00 – $1,450.00
+17.7% to target